Literature DB >> 9758056

Comparative and library epidemiological typing systems: outbreak investigations versus surveillance systems.

M J Struelens1, Y De Gheldre, A Deplano.   

Abstract

A number of high-resolution molecular typing systems have been developed in recent years. Their availability raises the new issues of selecting the method (s) best suited for a particular purpose and interpreting and communicating typing results. Most of the currently available methods are comparative only: they allow testing of a sample of isolates for delineation of those closely related from those markedly different in genomic backgrounds. This approach is adequate for outbreak investigation, allowing determination of clonal spread in a microenvironment and identification of the source of infection. Comparative methods with sufficient resolution for most pathogens include restriction fragment-length polymorphism (RFLP), pulsed-field gel electrophoresis (PFGE), and arbitrarily primed and randomly amplified polymorphic DNA-polymerase chain reaction (PCR) analysis. For surveillance systems, monitoring clonal spread and prevalence in populations over extended periods of time requires library typing systems. These must be standardized, must have a high throughput, and must use a uniform nomenclature. Promising or validated methods include serotyping, insertion sequence fingerprinting, ribotyping, PFGE, amplified fragment-length polymorphism (AFLP), infrequent-restriction-site amplification PCR, interrepetitive element PCR typing (rep-PCR) and PCR-RFLP of polymorphic loci. PCR methods generating arrays of size-specific amplicons (AFLP, rep-PCR) can be more reproducibly analyzed by using denaturing polyacrylamide gel or capillary electrophoresis with automated laser detection. Binary probe typing systems appear optimal and should be enhanced further through use of DNA chip technology. In these systems, amplification of polymorphic regions is followed by solid-phase hybridization with a reference panel of sequence-variant specific probes. The resulting binary type results allow determination of reproducible, numeric profiles. However, interpretation and nomenclature of typing results for large-scale surveillance purposes still require a better understanding of population structure and microevolution of most microbial pathogens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9758056     DOI: 10.1086/647874

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  22 in total

1.  Suitability of PCR fingerprinting, infrequent-restriction-site PCR, and pulsed-field gel electrophoresis, combined with computerized gel analysis, in library typing of Salmonella enterica serovar enteritidis.

Authors:  J Garaizar; N López-Molina; I Laconcha; D Lau Baggesen; A Rementeria; A Vivanco; A Audicana; I Perales
Journal:  Appl Environ Microbiol       Date:  2000-12       Impact factor: 4.792

2.  Evaluation of fluorescence-based amplified fragment length polymorphism analysis for molecular typing in hospital epidemiology: comparison with pulsed-field gel electrophoresis for typing strains of vancomycin-resistant Enterococcus faecium.

Authors:  N A Antonishyn; R R McDonald; E L Chan; G Horsman; C E Woodmansee; P S Falk; C G Mayhall
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

Review 3.  Role of genomic typing in taxonomy, evolutionary genetics, and microbial epidemiology.

Authors:  A van Belkum; M Struelens; A de Visser; H Verbrugh; M Tibayrenc
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

4.  Epidemiological validation of pulsed-field gel electrophoresis patterns for methicillin-resistant Staphylococcus aureus.

Authors:  D S Blanc; M J Struelens; A Deplano; R De Ryck; P M Hauser; C Petignat; P Francioli
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

5.  Comparative evaluation of three different genotyping methods for investigation of nosocomial outbreaks of Legionnaires' disease in hospitals.

Authors:  D Jonas; H G Meyer; P Matthes; D Hartung; B Jahn; F D Daschner; B Jansen
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

6.  The use of randomization tests to assess the degree of similarity in PFGE patterns of E. coli O157 isolates from known outbreaks and statistical space-time clusters.

Authors:  D L Pearl; M Louie; L Chui; K Doré; K M Grimsrud; S W Martin; P Michel; L W Svenson; S A McEwen
Journal:  Epidemiol Infect       Date:  2006-06-02       Impact factor: 2.451

7.  Increasing genetic diversity of Salmonella enterica serovar typhi isolates from papua new guinea over the period from 1992 to 1999.

Authors:  Kwai-Lin Thong; Yee-Ling Goh; Rohani M Yasin; Ming Guek Lau; Megan Passey; Gibson Winston; Mition Yoannes; Tikki Pang; John C Reeder
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

8.  Comparison of Staphylococcus aureus isolates from bovine and human skin, milking equipment, and bovine milk by phage typing, pulsed-field gel electrophoresis, and binary typing.

Authors:  R N Zadoks; W B van Leeuwen; D Kreft; L K Fox; H W Barkema; Y H Schukken; A van Belkum
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

9.  Molecular subtyping and characterization of bovine and human Streptococcus agalactiae isolates.

Authors:  Sharinne Sukhnanand; Belgin Dogan; Maranatha O Ayodele; Ruth N Zadoks; Mary Patricia J Craver; Nellie B Dumas; Ynte H Schukken; Kathryn J Boor; Martin Wiedmann
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

10.  Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options.

Authors:  Silvia Natoli; Carla Fontana; Marco Favaro; Alberto Bergamini; Gian Piero Testore; Silvia Minelli; Maria Cristina Bossa; Mauro Casapulla; Giorgia Broglio; Angela Beltrame; Laura Cudillo; Raffaella Cerretti; Francesca Leonardis
Journal:  BMC Infect Dis       Date:  2009-06-04       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.